Successful treatment of an unresectable choroid plexus carcinoma in a patient with Li-Fraumeni syndrome

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 1, 2005, Pages 46-49

  Dickens, David S ^a   Dothage, Judith A ^b   Heideman, Richard L ^c   Ballard, Edgar T ^b   Jubinsky, Paul T ^d  

^a HELEN DEVOS CHILDREN S HOSPITAL   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Brain tumor; Neurosurgery; p53; Pediatric oncology; Radiation therapy

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; PROTEIN P53;

AMINO ACID SUBSTITUTION; ARTICLE; BRAIN HEMORRHAGE; CASE REPORT; CHOROID PLEXUS TUMOR; COIL EMBOLIZATION; EXON; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; HEMISPHERECTOMY; HUMAN; IMMUNOHISTOCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA; CHILD, PRESCHOOL; CHOROID PLEXUS NEOPLASMS; CYCLOPHOSPHAMIDE; ETOPOSIDE; FEMALE; HUMANS; LI-FRAUMENI SYNDROME; MAGNETIC RESONANCE IMAGING; NEOPLASM METASTASIS;

EID: 12944260522     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000152569.60694.1f     Document Type: Article

References (30)

1. Ellenbogen RG, Winston KR, Kupsky WJ. Tumors of the choroid plexus in children. Neurosurgery. 1989;25:327-335.
2. Wolff JE, Sajedi M, Brant R, et al. Choroid plexus tumours. Br J Cancer. 2002;87:1086-1091.
3. Packer RJ, Perilongo G, Johnson D, et al. Choroid plexus carcinoma of childhood. Cancer. 1992;69:580-585.
4. Pierga JY, Kalifa C, Terrier-Lacombe MJ, et al. Carcinoma of the choroid plexus: a pediatric experience. Med Pediatr Oncol. 1993;21:480-487.
5. Pencalet P, Sainte-Rose C, Lellouch-Tubiana A, et al. Papillomas and carcinomas of the choroid plexus in children. J Neurosurg. 1998;88:521-528.
6. Allen J, Wisoff J, Helson L, et al. Choroid plexus carcinoma: responses to chemotherapy alone in newly diagnosed young children. J Neurooncol. 1992;12:69-74.
7. Berger C, Thiesse P, Lellouch-Tubiana A, et al. Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery. 1998;42:470-475.
8. St. Clair SK, Humphreys RP, Pillay PK, et al. Current management of choroid plexus carcinoma in children. Pediatr Neurosurg. 1991;17:225-233.
9. Duffner PK, Kun LE, Burger PC, et al. Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. The Pediatric Oncology Group. Pediatr Neurosurg. 1995;22:189-196.
10. Tonda ME, Heideman RL, Petros WP, et al. Carboplatin pharmacokinetics in young children with brain tumors. Cancer Chemother Pharmacol. 1996;38:395-400.
11. Chow E, Reardon DA, Shah AB, et al. Pediatric choroid plexus neoplasms. Int J Radiat Oncol Biol Phys. 1999;44:249-254.
12. Fiorillo A, Maggi G, Cirillo S, et al. Efficacy of sequential chemotherapy including methotrexate and doxorubicin in an infant with partially resected choroid plexus carcinoma. Pediatr Neurosurg. 2003;38:21-26.
13. Mahoney DH Jr, Cohen ME, Friedman HS, et al. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group Phase II study. Neurooncol. 2000;2:213-220.
14. Matsutani M. Combined chemotherapy and radiation therapy for CNS germ cell tumors: the Japanese experience. J Neurooncol. 2001;54:311-316.
15. Lopez-Aguilar E, Sepulveda-Vildosola AC, Rivera-Marquez H, et al. Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children. Childs Nerv Syst. 2003;19:818-823.
16. Baranzelli MC, Patte C, Bouffet E, et al. Nonmetastatic intracranial germinoma: the experience of the French Society of Pediatric Oncology. Cancer. 1997;80:1792-1797.
17. Jennings MT, Sposto R, Boyett JM, et al. Preradiation chemotherapy in primary high-risk brainstem tumors: phase II Study CCG-9941 of the Children's Cancer Group. J Clin Oncol. 2002;20:3431-3437.
18. Syndikus I, Tait D, Ashley S, et al. Long-term follow-up of young children with brain tumors after irradiation. Int J Radiat Oncol Biol Phys. 1994;30:781-787.
19. Sedlacek Z, Kodet R, Seemanova E, et al. Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours. Br J Cancer. 1998;77:1034-1039.
20. Vital A, Bringuier PP, Huang H, et al. Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations. J Neuropathol Exp Neurol. 1998;57:1061-1069.
21. Garber JE, Burke EM, Lavally BL, et al. Choroid plexus tumors in the breast cancer-sarcoma syndrome. Cancer. 1990;66:2658-2660.
22. Huusko P, Castren K, Launonen V, et al. Germ-line tp53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2. Cancer Genet Cytogenet. 1999;112:9-14.
23. Jolly KW, Malkin D, Douglass EC, et al. Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogene. 1994;9:97-102.
24. Malkin D, Chilton-MacNeill S, Meister LA, et al. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene. 2001;20:4441-4449.
25. Kirsch DG, Kastan MB. Tumor-suppressor p53: Implications for tumor development and prognosis. J Clin Oncol. 1998;16:3158-3168.
26. Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer. 2001;1:233-240.
27. Olivier M, Eeles R, Hollstein M, et al. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat. 2002;19:607-614.
28. Wagner J, Portwine C, Rabin K, et al. High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst. 1994;86:1707-1710.
29. Varley JM, McGown G, Thorncroft M, et al. Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet. 1999;65:995-1006.
30. Cadwell C, Zambetti GP. The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth. Gene. 2001;277:15-30.